FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2973117475> ?p ?o ?g. }

• W2973117475 endingPage "169" @default.
• W2973117475 startingPage "157" @default.
• W2973117475 abstract "Gene therapy is a promising strategy to cure rare diseases. The lack of regulatory sequences ensuring specific and robust expression in skeletal and cardiac muscle is a substantial limitation of gene therapy efficiency targeting the muscle tissue. Here we describe a novel muscle hybrid (MH) promoter that is highly active in both skeletal and cardiac muscle cells. It has an easily exchangeable modular structure, including an intronic module that highly enhances the expression of the gene driven by it. In cultured myoblasts, myotubes, and cardiomyocytes, the MH promoter gives relatively stable expression as well as higher activity and protein levels than the standard CMV and desmin gene promoters or the previously developed synthetic or CKM-based promoters. Combined with AAV2/9, the MH promoter also provides a high in vivo expression level in skeletal muscle and the heart after both intramuscular and systemic delivery. It is much more efficient than the desmin-encoding gene promoter, and it maintains the same specificity. This novel promoter has potential for gene therapy in muscle cells. It can provide stable transgene expression, ensuring high levels of therapeutic protein, and limited side effects because of its specificity. This constitutes an improvement in the efficiency of genetic disease therapy. Gene therapy is a promising strategy to cure rare diseases. The lack of regulatory sequences ensuring specific and robust expression in skeletal and cardiac muscle is a substantial limitation of gene therapy efficiency targeting the muscle tissue. Here we describe a novel muscle hybrid (MH) promoter that is highly active in both skeletal and cardiac muscle cells. It has an easily exchangeable modular structure, including an intronic module that highly enhances the expression of the gene driven by it. In cultured myoblasts, myotubes, and cardiomyocytes, the MH promoter gives relatively stable expression as well as higher activity and protein levels than the standard CMV and desmin gene promoters or the previously developed synthetic or CKM-based promoters. Combined with AAV2/9, the MH promoter also provides a high in vivo expression level in skeletal muscle and the heart after both intramuscular and systemic delivery. It is much more efficient than the desmin-encoding gene promoter, and it maintains the same specificity. This novel promoter has potential for gene therapy in muscle cells. It can provide stable transgene expression, ensuring high levels of therapeutic protein, and limited side effects because of its specificity. This constitutes an improvement in the efficiency of genetic disease therapy." @default.
• W2973117475 created "2019-09-19" @default.
• W2973117475 creator A5009194217 @default.
• W2973117475 creator A5016214270 @default.
• W2973117475 creator A5023146149 @default.
• W2973117475 creator A5031640092 @default.
• W2973117475 creator A5063387180 @default.
• W2973117475 creator A5073613815 @default.
• W2973117475 creator A5082503971 @default.
• W2973117475 creator A5091848433 @default.
• W2973117475 date "2019-12-01" @default.
• W2973117475 modified "2023-10-08" @default.
• W2973117475 title "A Muscle Hybrid Promoter as a Novel Tool for Gene Therapy" @default.
• W2973117475 cites W1486302160 @default.
• W2973117475 cites W1553789387 @default.
• W2973117475 cites W1849676176 @default.
• W2973117475 cites W1963948212 @default.
• W2973117475 cites W1965511290 @default.
• W2973117475 cites W1965997845 @default.
• W2973117475 cites W1970829763 @default.
• W2973117475 cites W1980491559 @default.
• W2973117475 cites W1989471545 @default.
• W2973117475 cites W1991625931 @default.
• W2973117475 cites W1996136504 @default.
• W2973117475 cites W2013319031 @default.
• W2973117475 cites W2016589083 @default.
• W2973117475 cites W2020685420 @default.
• W2973117475 cites W2028161903 @default.
• W2973117475 cites W2031887473 @default.
• W2973117475 cites W2033707631 @default.
• W2973117475 cites W2045848437 @default.
• W2973117475 cites W2047231717 @default.
• W2973117475 cites W2051722787 @default.
• W2973117475 cites W2054213109 @default.
• W2973117475 cites W2060061342 @default.
• W2973117475 cites W2062636522 @default.
• W2973117475 cites W2065979540 @default.
• W2973117475 cites W2066226950 @default.
• W2973117475 cites W2066619852 @default.
• W2973117475 cites W2074763310 @default.
• W2973117475 cites W2090220136 @default.
• W2973117475 cites W2095152514 @default.
• W2973117475 cites W2095592133 @default.
• W2973117475 cites W2100923281 @default.
• W2973117475 cites W2103417302 @default.
• W2973117475 cites W2105874194 @default.
• W2973117475 cites W2115744888 @default.
• W2973117475 cites W2121142896 @default.
• W2973117475 cites W2123864807 @default.
• W2973117475 cites W2123921145 @default.
• W2973117475 cites W2124157828 @default.
• W2973117475 cites W2126136539 @default.
• W2973117475 cites W2132935601 @default.
• W2973117475 cites W2137609813 @default.
• W2973117475 cites W2139880828 @default.
• W2973117475 cites W2141977071 @default.
• W2973117475 cites W2142890842 @default.
• W2973117475 cites W2144941304 @default.
• W2973117475 cites W2147775310 @default.
• W2973117475 cites W2148441137 @default.
• W2973117475 cites W2149137857 @default.
• W2973117475 cites W2150612336 @default.
• W2973117475 cites W2173845487 @default.
• W2973117475 cites W2291328046 @default.
• W2973117475 cites W2312371445 @default.
• W2973117475 cites W2318975430 @default.
• W2973117475 cites W2402426153 @default.
• W2973117475 cites W2509074752 @default.
• W2973117475 cites W2557431780 @default.
• W2973117475 cites W2770413228 @default.
• W2973117475 cites W2781382326 @default.
• W2973117475 cites W2884946171 @default.
• W2973117475 cites W2921210869 @default.
• W2973117475 doi "https://doi.org/10.1016/j.omtm.2019.09.001" @default.
• W2973117475 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6807297" @default.
• W2973117475 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31660418" @default.
• W2973117475 hasPublicationYear "2019" @default.
• W2973117475 type Work @default.
• W2973117475 sameAs 2973117475 @default.
• W2973117475 citedByCount "15" @default.
• W2973117475 countsByYear W29731174752020 @default.
• W2973117475 countsByYear W29731174752021 @default.
• W2973117475 countsByYear W29731174752022 @default.
• W2973117475 countsByYear W29731174752023 @default.
• W2973117475 crossrefType "journal-article" @default.
• W2973117475 hasAuthorship W2973117475A5009194217 @default.
• W2973117475 hasAuthorship W2973117475A5016214270 @default.
• W2973117475 hasAuthorship W2973117475A5023146149 @default.
• W2973117475 hasAuthorship W2973117475A5031640092 @default.
• W2973117475 hasAuthorship W2973117475A5063387180 @default.
• W2973117475 hasAuthorship W2973117475A5073613815 @default.
• W2973117475 hasAuthorship W2973117475A5082503971 @default.
• W2973117475 hasAuthorship W2973117475A5091848433 @default.
• W2973117475 hasBestOaLocation W29731174751 @default.
• W2973117475 hasConcept C101762097 @default.
• W2973117475 hasConcept C102230213 @default.
• W2973117475 hasConcept C104317684 @default.
• W2973117475 hasConcept C105702510 @default.

• next